
Arcutis
Focuses on medical dermatology, leveraging innovations in inflammation and immunology.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
* | N/A | $150m | Post IPO Equity |
Total Funding | 000k |








USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | - | - | 1517 % | 230 % | 69 % | 32 % | 34 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | - | (8025 %) | (382 %) | (56 %) | (11 %) | 3 % | 14 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | - | (8450 %) | (440 %) | (71 %) | (18 %) | 5 % | 29 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
R&D % of revenue | - | 4949 % | 186 % | 39 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Arcutis Biotherapeutics is a biopharmaceutical company specializing in the development of innovative therapies for dermatological diseases. The company focuses on filling the innovation gap in medical dermatology by leveraging recent advancements in inflammation and immunology. Arcutis serves patients suffering from skin conditions such as psoriasis, eczema, and seborrheic dermatitis. Operating in the biopharmaceutical market, the company employs a business model centered around research and development, clinical trials, and commercialization of its proprietary drug formulations. Revenue is generated through the sale of these specialized therapies once they receive regulatory approval. The leadership team, which includes top dermatologists and a leading topical drug formulator, brings unparalleled expertise to the company's mission of becoming a leader in dermatological innovation.
Keywords: biopharmaceutical, dermatology, psoriasis, eczema, seborrheic dermatitis, inflammation, immunology, drug development, clinical trials, proprietary formulations.
Tech stack
Investments by Arcutis
Edit